EUR 44.35
(0.45%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.13 Billion EUR | 20.98% |
2022 | 1.76 Billion EUR | 1.7% |
2021 | 1.73 Billion EUR | 3.99% |
2020 | 1.66 Billion EUR | 22.15% |
2019 | 1.36 Billion EUR | 44.64% |
2018 | 944.79 Million EUR | 2.06% |
2017 | 925.68 Million EUR | 1.33% |
2016 | 913.53 Million EUR | 2.52% |
2015 | 891.1 Million EUR | 6.42% |
2014 | 837.31 Million EUR | 4.74% |
2013 | 799.43 Million EUR | 6.13% |
2012 | 753.22 Million EUR | 3.58% |
2011 | 727.21 Million EUR | 5.38% |
2010 | 690.1 Million EUR | 4.13% |
2009 | 662.72 Million EUR | 1.22% |
2008 | 654.72 Million EUR | 12.57% |
2007 | 581.6 Million EUR | 9.06% |
2006 | 533.26 Million EUR | 6.32% |
2005 | 501.56 Million EUR | 12.29% |
2004 | 446.66 Million EUR | -16.89% |
2003 | 537.41 Million EUR | 41.54% |
2002 | 379.69 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.23 Billion EUR | 0.0% |
2024 Q1 | - EUR | -100.0% |
2023 Q1 | 1.82 Billion EUR | 3.51% |
2023 Q3 | - EUR | -100.0% |
2023 Q2 | 1.82 Billion EUR | 0.04% |
2023 Q4 | 1.98 Billion EUR | 0.0% |
2023 FY | 2.13 Billion EUR | 20.98% |
2022 Q2 | 1.78 Billion EUR | 0.11% |
2022 Q1 | 1.78 Billion EUR | 2.82% |
2022 Q3 | 1.71 Billion EUR | -4.19% |
2022 FY | 1.76 Billion EUR | 1.7% |
2022 Q4 | 1.76 Billion EUR | 3.13% |
2021 Q1 | 1.69 Billion EUR | 1.5% |
2021 Q3 | 1.71 Billion EUR | 0.27% |
2021 Q4 | 1.73 Billion EUR | 1.22% |
2021 FY | 1.73 Billion EUR | 3.99% |
2021 Q2 | 1.71 Billion EUR | 0.95% |
2020 Q3 | 1.43 Billion EUR | 4.77% |
2020 FY | 1.66 Billion EUR | 22.15% |
2020 Q4 | 1.66 Billion EUR | 16.18% |
2020 Q2 | 1.37 Billion EUR | -1.96% |
2020 Q1 | 1.39 Billion EUR | 2.36% |
2019 Q4 | 1.36 Billion EUR | 0.76% |
2019 Q3 | 1.35 Billion EUR | -5.48% |
2019 Q2 | 1.43 Billion EUR | 2.4% |
2019 FY | 1.36 Billion EUR | 44.64% |
2019 Q1 | 1.4 Billion EUR | 48.32% |
2018 Q3 | 935.68 Million EUR | -6.79% |
2018 Q1 | 982.46 Million EUR | 6.13% |
2018 FY | 944.79 Million EUR | 2.06% |
2018 Q2 | 1 Billion EUR | 2.17% |
2018 Q4 | 944.79 Million EUR | 0.97% |
2017 FY | 925.68 Million EUR | 1.33% |
2017 Q4 | 925.68 Million EUR | 2.41% |
2017 Q3 | 903.87 Million EUR | 6.26% |
2017 Q2 | 850.63 Million EUR | -12.44% |
2017 Q1 | 971.49 Million EUR | 6.34% |
2016 Q2 | 977.45 Million EUR | 4.72% |
2016 FY | 913.53 Million EUR | 2.52% |
2016 Q4 | 913.53 Million EUR | 3.46% |
2016 Q3 | 882.98 Million EUR | -9.66% |
2016 Q1 | 933.36 Million EUR | 4.74% |
2015 FY | 891.1 Million EUR | 6.42% |
2015 Q1 | 916.31 Million EUR | 9.43% |
2015 Q4 | 891.1 Million EUR | 2.95% |
2015 Q3 | 865.58 Million EUR | -7.9% |
2015 Q2 | 939.84 Million EUR | 2.57% |
2014 Q2 | 892.85 Million EUR | 1.98% |
2014 Q1 | 875.52 Million EUR | 9.52% |
2014 FY | 837.31 Million EUR | 4.74% |
2014 Q4 | 837.31 Million EUR | 1.22% |
2014 Q3 | 827.19 Million EUR | -7.35% |
2013 Q1 | 806.74 Million EUR | 7.1% |
2013 FY | 799.43 Million EUR | 6.13% |
2013 Q4 | 799.43 Million EUR | 3.41% |
2013 Q3 | 773.03 Million EUR | -7.18% |
2013 Q2 | 832.82 Million EUR | 3.23% |
2012 Q4 | 753.22 Million EUR | 2.23% |
2012 Q3 | 736.83 Million EUR | -8.74% |
2012 Q2 | 807.36 Million EUR | 2.55% |
2012 Q1 | 787.32 Million EUR | 8.27% |
2012 FY | 753.22 Million EUR | 3.58% |
2011 Q3 | 717.34 Million EUR | -6.6% |
2011 Q1 | 746.36 Million EUR | 8.15% |
2011 Q2 | 768.01 Million EUR | 2.9% |
2011 Q4 | 727.21 Million EUR | 1.38% |
2011 FY | 727.21 Million EUR | 5.38% |
2010 Q3 | 694.91 Million EUR | -6.51% |
2010 FY | 690.1 Million EUR | 4.13% |
2010 Q4 | 690.1 Million EUR | -0.69% |
2010 Q1 | 711.29 Million EUR | 7.33% |
2010 Q2 | 743.28 Million EUR | 4.5% |
2009 FY | 662.72 Million EUR | 1.22% |
2009 Q4 | 662.72 Million EUR | 0.0% |
2008 FY | 654.72 Million EUR | 12.57% |
2007 FY | 581.6 Million EUR | 9.06% |
2006 FY | 533.26 Million EUR | 6.32% |
2005 FY | 501.56 Million EUR | 12.29% |
2004 FY | 446.66 Million EUR | -16.89% |
2003 FY | 537.41 Million EUR | 41.54% |
2002 FY | 379.69 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 1.23 Billion EUR | -73.38% |
Carl Zeiss Meditec AG | 3.03 Billion EUR | 29.581% |
Gerresheimer AG | 3.42 Billion EUR | 37.718% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 78.107% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 78.107% |